Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parvathi Ranganathan

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR BindingParvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Cancer Discovery|June 30, 2016
Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid LeukemiaSophia E Maharry, Christopher J Walker, Sandya Liyanarachchi, et al.
Blood Advances|October 18, 2018
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHDSarah A Wall, Qiuhong Zhao, Martha Yearsley, et al.
Frontiers in Oncology|November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host DiseaseKatiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Leukemia|August 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphomaAnuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, et al.
Leukemia & Lymphoma|September 4, 2023
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemiaBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia responseRathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR BindingParvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Cancer Discovery|June 30, 2016
Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid LeukemiaSophia E Maharry, Christopher J Walker, Sandya Liyanarachchi, et al.
Blood Advances|October 18, 2018
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHDSarah A Wall, Qiuhong Zhao, Martha Yearsley, et al.
Frontiers in Oncology|November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host DiseaseKatiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Leukemia|August 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphomaAnuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, et al.
Leukemia & Lymphoma|September 4, 2023
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemiaBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia responseRathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
Pageof 4